Keywords: داروسازی اقتصاد; budget impact; cost-effectiveness; Czech Republic; highly innovative drug program; orphan; pharmacoeconomics; pricing and reimbursement;
مقالات ISI داروسازی اقتصاد (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: داروسازی اقتصاد; health technology assessment; optimal choice of treatment plan; pharmacoeconomics;
Keywords: داروسازی اقتصاد; Antimicrobial stewardship; Pharmacoeconomics; Oral antibiotic therapy; Cost;
Keywords: داروسازی اقتصاد; health policies; health technology assessment; pharmacoeconomics; reimbursement;
Keywords: داروسازی اقتصاد; China; drug policies; health technology assessment; pharmacoeconomics; regulation;
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Health economics; Generic drugs; Generic pharmaceutical pricing; Reimbursement; Internal reference pricing;
Keywords: داروسازی اقتصاد; Antipsychotics; Psychosis; Schizophrenia; Cost; Pharmacoeconomics; Antipsicóticos; Psicosis; Esquizofrenia; Coste; FarmacoeconomÃa;
Keywords: داروسازی اقتصاد; FarmacoeconomÃa; Estancia hospitalaria; Terapia secuencial; Pharmacoeconomics; Length of stay; Switch therapy;
Keywords: داروسازی اقتصاد; Blood glucose test strips; Diabetes mellitus; Healthcare economics; Pharmacoeconomics; Self-monitoring blood glucose;
Keywords: داروسازی اقتصاد; adverse drug event; health care costs; medical records; pharmacoeconomics;
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Orphan disease; Hereditary angioedema; Burden; Treatment;
Keywords: داروسازی اقتصاد; Severe asthma; Biologic therapy; Pharmacoeconomics; Health care resource use; Oral corticosteroid; Personalized medicine;
Keywords: داروسازی اقتصاد; health care policy; Europe; pharmacoeconomics; reimbursement; Serbia; targeted cancer therapy;
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Health economics; Outcomes research; Fellowship; Program curriculum; Guidelines; Improvements;
Keywords: داروسازی اقتصاد; Saudi Arabia; Pharmacoeconomics; Cost-minimization analysis; Moderate to severe infections; Antibiotics; Antimicrobial therapy; Carbapenems; Imipenem; Meropenem
Keywords: داروسازی اقتصاد; Asia; health care; HTA; innovative technologies; patients; pharmaceuticals; pharmacoeconomics; population;
Keywords: داروسازی اقتصاد; Buprenorphine; Adherence; Opiate; Opioid; Dependence; Pharmacoeconomics;
Keywords: داروسازی اقتصاد; Parenteral; Nutrition; Omega-3; Model; Cost; Pharmacoeconomics;
Keywords: داروسازی اقتصاد; China; cost-effectiveness analysis (CEA); pharmacoeconomics; Quality of Health Economic Studies (QHES);
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Prescribing behavior; Drug price; Health policy; China;
Keywords: داروسازی اقتصاد; Drug resistance; Epilepsy surgery; Pharmacoeconomics; Pharmacoresistance; Reimbursement;
Keywords: داروسازی اقتصاد; biological agents; cost effectiveness; drug therapy; pharmacoeconomics; psoriasis
Supplemental parenteral nutrition in intensive care patients: A cost saving strategy
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Supplemental parenteral nutrition; Intensive care unit; Cost-effectiveness; Energy requirements; Infections;
Concern over cost of and access to cancer treatments: A meta-narrative review of nivolumab and pembrolizumab studies
Keywords: داروسازی اقتصاد; ASCO; American Society of Clinical Oncology; BRAF; B-raf proto-oncogene, serine/threonine kinase; CTLA4; cytotoxic T-lymphocyte associated protein 4; ESMO; European Society for Medical Oncology; FDA; Food and Drug Administration; ICER; incremental cost-ef
Hospitalizaciones y análisis económico en pacientes psicóticos con palmitato de paliperidona de larga duración
Keywords: داروسازی اقتصاد; Antipsicóticos; Psicosis; Esquizofrenia; Coste; FarmacoeconomÃa; Antipsychotics; Psychosis; Schizophrenia; Cost; Pharmacoeconomics;
Resource Utilization After Snakebite Severity Score Implementation into Treatment Algorithm of Crotaline Bite
Keywords: داروسازی اقتصاد; snake bite; envenomation; antivenin; clinical pharmacy; outcomes; pharmacoeconomics;
Featured ArticleThe Predictors study: Development and baseline characteristics of the Predictors 3 cohort
Keywords: داروسازی اقتصاد; MCI; ADL; Cognitive function; Extrapyramidal signs; Psychotic features; Pharmacoeconomics; Prediction algorithms;
Calidad de vida del paciente asmático con beclometasona/formoterol. Análisis de coste-utilidad
Keywords: داروسازی اقتصاد; Asma; Calidad de vida; Farmacoeconomía; Análisis coste-utilidad; Beclometasona; FormoterolAsthma; Quality of life; Pharmacoeconomics; Cost-utility analysis; Beclomethasone; Formoterol
Clinical Utility and Economic Impact of CYP2D6 Genotyping
Keywords: داروسازی اقتصاد; CYP2D6; CYP2D6 genotyping; Pharmacogenetics; Pharmacoeconomics;
Pharmacoeconomics education in WHO Eastern Mediterranean region
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Curriculum; Pharmacy; Education;
Cost-effectiveness analysis of EGFR mutation testing and gefitinib as first-line therapy for non-small cell lung cancer
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Cost-effectiveness analysis; Non-small cell lung cancer; Gefitinib; Individualized medicine;
ReviewCost-Effectiveness of Adjuvant Chemotherapy in the Treatment of Early-Stage Colon Cancer
Keywords: داروسازی اقتصاد; Capecitabine; Cost-effectiveness analysis; 5-Fluorouracil; Oxaliplatin; Pharmacoeconomics; Stage III colon cancer;
Gasto económico del tratamiento del dolor irruptivo
Keywords: داروسازی اقتصاد; Dolor; Dolor irruptivo oncológico; Fentanilo; Impacto presupuestario; Coste-utilidad; FarmacoeconomÃa; Pain; Breakthrough cancer pain; Fentanyl; Budget impact; Cost-utility; Pharmacoeconomics;
Featured ArticleDependence in Alzheimer's disease and service use costs, quality of life, and caregiver burden: The DADE study
Keywords: داروسازی اقتصاد; Dependence; Alzheimer's disease; Quality of life; Caregiver burden; Service use costs; Pharmacoeconomics; England;
Cost-minimization Analysis of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients With Primary Immunodeficiency
Keywords: داروسازی اقتصاد; cost minimization; home-based therapy; immunoglobulin replacement therapy; pharmacoeconomics; productivity loss; subcutaneous IgG;
Evolución de la utilización de antidepresivos, ansiolíticos e hipnóticos en la Comunitat Valenciana. Período 2000-2010
Keywords: داروسازی اقتصاد; Antidepresivos; Ansiolíticos; Hipnóticos; Utilización de medicamentos; Gasto farmacéuticoAntidepressants; Anxiolytics; Hypnotics; Drug utilization; Pharmacoeconomics
Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Lower respiratory tract infections; Community-acquired pneumonia; Antibiotic therapy; ICU
Cost-effectiveness analysis of antiepileptic drugs in the treatment of Lennox-Gastaut syndrome
Keywords: داروسازی اقتصاد; Lennox-Gastaut syndrome; Clobazam; Cost effectiveness; Antiepileptic drug; Epilepsy; Budget impact modeling; Pharmacoeconomics;
Exploring the state of pharmacy profession: The perspective of Côte d'Ivoire
Keywords: داروسازی اقتصاد; Pharmacy education; Pharmacy practice; Pharmacoeconomics; Pharmaceutical care; Côte d'Ivoire;
Challenging sequential approach to treatment resistant depression: Cost-utility analysis based on the Sequenced Treatment Alternatives to Relieve Depression (STARâD) trial
Keywords: داروسازی اقتصاد; Depression; Antidepressants; Pharmacoeconomics; Cost-benefit; Switching;
Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Asthma in Japan and the Value of Responder Prediction Methods Based on a Multinational Trial
Keywords: داروسازی اقتصاد; costs and benefits; decision making; economic evaluation; pharmacoeconomics; value of information;
Pharmacoeconomics and outcomes research degree-granting PhD programs in the United States
Keywords: داروسازی اقتصاد; Outcomes research; Pharmacoeconomics; Graduate training; Education; PhD programs
Pharmacoeconomics of Hematopoietic Stem Cell Mobilization: An Overview of Current Evidence and Gaps in the Literature
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Mobilization; Autologous; Plerixafor; Costs; Failure to mobilize
Analysis of Inpatient Use of Fresh Frozen Plasma and Other Therapies and Associated Outcomes in Patients with Major Bleeds from Vitamin K Antagonism
Keywords: داروسازی اقتصاد; fresh frozen plasma; pharmacoeconomics; transfusion; transfusion-associated circulatory overload; warfarin
The Impact of Medication Adherence on Coronary Artery Disease Costs and Outcomes: A Systematic Review
Keywords: داروسازی اقتصاد; Coronary artery disease; Costs; Medication adherence; Outcomes; Pharmacoeconomics; Systematic review;
Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs
Keywords: داروسازی اقتصاد; β-Lactams; Ventilator-associated pneumonia; Pharmacokinetics; Piperacillin; Pharmacoeconomics;
Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Levonorgestrel-releasing intrauterine system; Mirena; Heavy menstrual bleeding; Hysterectomy
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
Keywords: داروسازی اقتصاد; MDD; major depressive disorder; HRQoL; health-related quality of life; GDP; gross domestic product; PPP; purchase power parity; CUA; cost-utility analysis; QALW; quality-adjusted life week; ICER; incremental cost-effectiveness ratio; CEAC; cost-effectiven
Pharmacoeconomic Analysis of Capecitabine versus 5-Fluorouracil/Leucovorin as Adjuvant Therapy for Stage III Colon Cancer in Taiwan
Keywords: داروسازی اقتصاد; 5-fluorouracil/leucovorin; adjuvant therapy; capecitabine; colon cancer; pharmacoeconomics;
The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia
Keywords: داروسازی اقتصاد; Pharmacoeconomics; Formulary decision; Pharmacy and Therapeutics committees; Saudi Arabia